HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

nemadipine-A

structure in first source

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - nemadipine-A: 4

Experts

1.	Li, Ling: 1 article (06/2022)
2.	Oltean, Sebastian: 1 article (06/2022)
3.	Stevens, Megan: 1 article (06/2022)
4.	Zheng, Jinxia: 1 article (06/2022)
5.	Cho, Dong-Hyung: 1 article (01/2013)
6.	Hwang, Jung Jin: 1 article (01/2013)
7.	Jeong, Seong-Yun: 1 article (01/2013)
8.	Jin, Dong-Hoon: 1 article (01/2013)
9.	Jo, Yoon Kyung: 1 article (01/2013)
10.	Kim, Eun Sung: 1 article (01/2013)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2013 - "Thus, combination of TRAIL with nemadipine-A may serve a new therapeutic scheme for the treatment of TRAIL resistant cancer cells, suggesting that a detailed study of this combination would be useful. " 06/09/2022 - "The administration of nemadipine-A intraperitoneally in a nude mouse xenograft model of prostate cancer slowed tumor growth. " 01/01/2013 - "Down-Regulation of Survivin by Nemadipine-A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis." 01/01/2013 - "In this report, we have found that nemadipine-A, a cell-permeable L-type calcium channel inhibitor, sensitizes TRAIL-resistant cancer cells to this ligand. "
2.	Prostatic Neoplasms (Prostate Cancer) 06/09/2022 - "The administration of nemadipine-A intraperitoneally in a nude mouse xenograft model of prostate cancer slowed tumor growth. "
3.	Necrosis 01/01/2013 - "Combination treatments using TRAIL with nemadipine-A synergistically induced both the caspase cascade and apoptotic cell death, which were blocked by a pan caspase inhibitor (zVAD) but not by autophagy or a necrosis inhibitor. "
4.	Muscular Dystrophies (Muscular Dystrophy) 01/01/2012 - "elegans model of dystrophin-based muscular dystrophy can be suppressed by clp-1 inactivation and that nemadipine-A inhibition of the EGL-19 calcium channel reveals that Ca(2+) dysfunction underlies the C. "
5.	Hypertension (High Blood Pressure) 05/04/2006 - "Nemadipine-A resembles a class of widely prescribed anti-hypertension drugs called the 1,4-dihydropyridines (DHPs) that antagonize the alpha1-subunit of L-type calcium channels. "

Related Drugs and Biologics

1.	L-Type Calcium Channels (Dihydropyridine Receptor)
2.	Caspases
3.	Dystrophin
4.	Calcium Channels (Calcium Channel)
5.	Ligands
6.	Survivin